News

Simply Better Brands Corp. Announces Execution of Non-Binding Term Sheet to Acquire CFH Limited, a Seed-To-Shelf CBD Manufacturer, to Support Accelerated Growth

Acquisition enables expanded vertical integration, research-driven innovation and cost synergies on the PureKana Wellness BrandVANCOUVER, British Columbia, April 27, 2022…

2 years ago

ContraFect Data Presentations at the 32nd Annual ECCMID Meeting Highlight the Potential of Engineered Lysin CF-370 to Improve Clinical Outcomes and Suppress Antimicrobial Resistance Compared to Antibiotics Alone

Oral Session Demonstrates CF-370’s Potent Activity in a Rabbit Pneumonia Model of an Extensively-Resistant Pseudomonas aeruginosa InfectionYONKERS, N.Y., April 27,…

2 years ago

InnerScope Hearing Technologies (OTC: INND) Launches New eCommerce Website with the Rebranding of iHEAR Direct-to-Consumer Hearing Aids

The New Relaunch of iHEARdirect.com Website Includes: Enhanced Customer FeaturesFree Online Hearing ScreeningHearing Aid & Hearing Loss Information BlogSeries of…

2 years ago

Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time

RALEIGH, N.C., April 27, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers…

2 years ago

Ashvattha Therapeutics Announces $69 Million in Series B Financing and up to $45M Exclusive License Agreement with Huadong to Advance Hydroxyl Dendrimer-Based Precision Medicines

– Series B Financing led by Huadong Medicine Investment Holding Co., Ltd, with participation from Natural Capital Investment Fund, Plum…

2 years ago

Achieve Life Sciences Announces Successful, Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Clinically robust and statistically significant results in primary and secondary endpoints for both 6- and 12-week cytisinicline treatment compared to…

2 years ago

Heat Biologics (NightHawk Biosciences) Announces that its Elusys Therapeutics Subsidiary has Executed a Contract to Deliver ANTHIM® to the Canadian Government

New contract marks the first international sale of ANTHIM® and follows recent acquisition of Elusys by NightHawkDURHAM, N.C., April 27,…

2 years ago

Theratechnologies to Focus Its Commercialization Activities on the North American Territory

MONTREAL, April 27, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused…

2 years ago

Solid Biosciences Announces Updated Corporate Strategy to Develop SGT-001 and SGT-003 Pipeline Programs for Patients with Duchenne Muscular Dystrophy

- IGNITE DMD functional and durability patient data support advancement of SGT-001; Program transitioning to a commercially scaled transient transfection-based…

2 years ago

Nephros First Quarter 2022 Financial Results Conference Call

SOUTH ORANGE, NJ, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen…

2 years ago